Executive Summary
The overnight tape is dominated by a broad-based upward revision in industrial and consumer-technology earnings power: Embraer raised 2026 revenue guidance to $8.4-8.6B and FCF to >$700M (from >$400M), Honda posted H1 operating profit +48.1% YoY, Sony H1 operating income +42.9% YoY, and ASE October revenue +47.1% YoY — a coherent picture of cyclical recovery plus AI/semiconductor demand.
At the same time, insider activity skews decisively negative at the top of the market: FIGS CEO Catherine Spear had 4.55M shares withheld for taxes at $21.58 (~$98.2M), Progyny's CEO and Executive Chairman sold a combined ~$10.3M under 10b5-1 plans, Chime's DST Global sold ~$18.4M, and Newbury Street's 10% holder Alpine Global liquidated ~$2.3M — a cluster of large-cap growth insiders monetizing into strength. Deal activity is picking up with two SPAC/merger communications (ACP Holdings/May Mobility with a $120M PIPE and a Nov 12 Investor Day; Werewolf/Ambros at a ~$697.5M combined valuation with a $150M PIPE) and Brookfield Business Partners' 20-F showing a 32.4% revenue decline to $27.5B driven by dispositions but a swing to positive net income attributable to unitholders ($43M vs -$109M). Distress is isolated but acute: Fusemachines' S-3 discloses Nasdaq delisting proceedings and going-concern risk, while Crona Corp. reports zero cash and zero revenue. The dominant cross-cutting theme is margin expansion on cost discipline (Honda SG&A down, Embraer EBIT margin up 230 bps, Sony OI +42.9%) offset by a visible H2 deceleration risk (Honda's implied H2 operating profit of ~$131B vs H1's $648.7B) and heavy insider selling in high-multiple consumer names.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13G · Form 4 · Schedule 13D · 20-F · S-3 · 10-Q · 8-K · DEFA14A · 13F · 10-K · 425
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from November 09, 2026.
Investment Signals (12)
- Embraer (ERJ) (BULLISH)▲
3Q26 revenue $2.3B (+17% YoY) with adjusted EBIT margin expanding to 10.9% from 8.6% (ex-tariff margin 16.0% vs 14.7%), record backlog $35.7B (+14% YoY, 8th consecutive all-time high), and 2026 guidance raised on revenue ($8.4-8.6B from $8.2-8.5B) and FCF (>$700M from >$400M) — a rare double upgrade without raising delivery volumes
- Honda (HMC) (BULLISH)▲
H1 FY2026 operating profit surged 48.1% YoY to ¥648.7B and profit attributable to owners jumped 65.7% to ¥516.8B (EPS ¥132.75 vs ¥76.30), with SG&A declining to ¥1,076B from ¥1,126.5B — cost discipline driving operating leverage
- Sony Group (SONY) (BULLISH)▲
H1 FY2026 sales +9.4% YoY to ¥6.27T with operating income +42.9% to ¥1,098.8B and net income +32.2% to ¥791.8B; diluted EPS ¥134.30 vs ¥99.22, and equity ratio recovered to 51.3% from 21.3% — a dramatic balance-sheet and earnings inflection from last year's ¥326.9B net loss
- ASE Technology (ASX) (BULLISH)▲
October net revenue NT$88.6B (+47.1% YoY), with ATM packaging/testing at NT$56.8B (+57.7% YoY, +7.9% MoM) — AI-driven advanced packaging demand remains the strongest sub-segment in the semiconductor supply chain
- NexPoint Residential Trust (NXRT) (BULLISH)▲
Three separate insiders bought on the open market within days — McGraner Matt 11,992 shares (~$199K at $16.38-16.86), Richards Paul 6,300 shares (~$103K at $15.91-16.78) — coordinated insider accumulation near $16-17 despite a director sale of 15,000 shares at $17.07
- CS Disco (LAW) (BULLISH)▲
CEO Friedrichsen Eric bought 4,490 shares at $5.45 (~$24.5K), adding to a 1.44M-share position — a small but directionally positive open-market purchase by the top executive
- FIGS (FIGS) (BEARISH)▲
CEO Catherine Spear exercised 8.595M options at $0.85-$1.37 and had 4,550,716 shares withheld for taxes at $21.58 (~$98.2M), leaving 1.67M shares — massive dilution-adjacent monetization at a high price signals the CEO is converting low-basis equity into cash at current valuations
- Progyny (PGNY) (BEARISH)▲
CEO Anevski sold 126,204 shares (~$4.51M) and Executive Chairman Schlanger sold 161,208 shares (~$5.76M) at ~$35.73, both under 10b5-1 plans, with Schlanger retaining only 238,462 shares — combined ~$10.3M of insider sales at a stock trading near $35
- Chime Financial (CHYM) (BEARISH)▲
10% owner DST Global Advisors sold 591,059 Class A shares (~$18.4M) across 21 transactions at ~$31.11-$32.10, retaining just 324,365 shares — a near-complete exit by a major pre-IPO holder
- Brookfield Business Partners (BBU) (BULLISH)▲
2025 20-F shows revenue down 32.4% to $27.5B (from $40.6B) on dispositions, but net income attributable to unitholders swung to +$43M from -$109M and the company closed $1.3B Antylia Scientific and $2.6B First National Financial deals plus a ~$950M Fosber agreement — portfolio rotation toward higher-quality cash flow
- Atour Lifestyle (ATAT) (BULLISH)▲
6-K furnishes Q3 2026 results plus a cash dividend announcement — a rare combination of growth disclosure and capital return from a China consumer name
- Equinor (EQNR) (BULLISH)▲
Fourth buyback tranche repurchased 974,300 shares for NOK 409.6M at an average NOK 420.35, with daily volumes rising (136K to 149K) as prices fell ~8.9% (NOK 432.94 to 394.44) — opportunistic counter-cyclical capital deployment
Risk Flags (10)
- Honda (HMC) H2 Deceleration [HIGH RISK]▼
Full-year guidance of ¥780B operating profit implies H2 operating profit of only ~¥131B versus H1's ¥648.7B — a ~80% sequential collapse in run-rate that the market may not have fully priced
- Fusemachines (FUSE) Delisting & Going Concern [HIGH RISK]▼
S-3 shelf discloses Nasdaq continued-listing deficiencies and delisting proceedings, liquidity and going-concern risks, and August 2026 convertible notes whose terms could trigger default on loss of exchange listing — with only 32.5M shares outstanding
- Crona Corp. (CROO) Zero Liquidity↓ [HIGH RISK]▼
10-Q shows $0 cash at both March 31 and December 31, 2025, zero revenue, net loss of $6,567, stockholders' deficit widened to $223,934, and liabilities of $232,765 funded by director advances — effectively a shell with no operating cash flow
- FIGS (FIGS) Insider Monetization [HIGH RISK]▼
CEO had 4.55M shares withheld at $21.58 (~$98.2M) after exercising 8.595M options at $0.85-$1.37 — the scale of low-basis conversion at current prices is a classic top-of-range insider signal
- Progyny (PGNY) Dual Insider Selling [HIGH RISK]▼
CEO and Executive Chairman sold ~$10.3M combined at ~$35.73 in the same window under 10b5-1 plans; Schlanger's remaining 238,462 shares represent a small residual stake
- Chime (CHYM) Sponsor Exit [HIGH RISK]▼
DST Global's 21-transaction sale of 591,059 shares (~$18.4M) leaves only 324,365 shares — near-total liquidation by a 10% owner removes a key holder and signals limited conviction post-lockup
- ASE Technology (ASX) Non-ATM Weakness [MEDIUM RISK]▼
Consolidated October revenue grew only +0.6% MoM despite ATM +7.9%, implying non-ATM (EMS) revenue fell ~10.4% sequentially to ~NT$31.8B from NT$35.5B — a hidden deterioration masked by the headline +47.1% YoY
- Embraer (ERJ) Delivery Back-Loading [MEDIUM RISK]▼
9M26 commercial deliveries of 52 aircraft are only 63% of the 80-85 guidance midpoint (vs 70% for executive aviation), requiring a heavy Q4 to hit targets — execution risk on the raised guidance
- Werewolf/Ambros Merger Structure↓ [HIGH RISK]▼
Werewolf holders receive only ~6.4% pro forma ownership vs Ambros ~72.0% and PIPE ~21.6%, and the lead asset neridronate has no FDA approval and depends on a single Phase 3 (CRPS-RISE) that may not stop early for efficacy — binary clinical and structural dilution risk
- Brookfield Business Partners (BBU) Revenue Erosion [MEDIUM RISK]▼
Revenue has fallen two consecutive years (-26.2% in 2024, -32.4% in 2025) to $27.5B, and Adjusted EBITDA declined 6.1% to $2,409M — the disposition-driven shrinkage is outpacing reinvestment
Opportunities (10)
- Embraer (ERJ) Guidance Raise + Backlog (OPPORTUNITY)◆
Record $35.7B backlog (+14% YoY) with book-to-bill of 1.5x consolidated and 2.9x in Defense & Security, plus FCF guidance nearly doubled to >$700M — the FCF upgrade is the highest-quality signal in the batch and supports re-rating
- NexPoint Residential (NXRT) Insider Cluster Buy (OPPORTUNITY)◆
Three insiders bought ~$300K of stock at $15.91-$16.86 within days, directly below a director's $17.07 sale — the buy-side conviction at multi-week lows offers a sentiment floor
- Sony (SONY) Earnings Inflection (OPPORTUNITY)◆
Operating income +42.9% YoY and EPS ¥134.30 vs ¥99.22, with equity ratio restored to 51.3% from 21.3% — the prior-year ¥326.9B net loss is now clearly a one-off, and the balance-sheet repair supports buyback capacity
- ACP Holdings/May Mobility (ACGC) Investor Day↓ (OPPORTUNITY)◆
Nov 12, 2026 Investor Day (3:00-4:30 PM ET) with a fully committed $120M PIPE and a four-conference roadshow through December (Barclays Nov 19, UBS Nov 30, Raymond James Dec 7, Bernstein Dec 9) — a dense catalyst calendar for the autonomous-vehicle SPAC
- Atour Lifestyle (ATAT) Q3 + Dividend (OPPORTUNITY)◆
6-K furnishes Q3 2026 results alongside a cash dividend announcement — the combination of growth and capital return is rare among China ADRs and could drive a re-rating if results confirm
- Equinor (EQNR) Counter-Cyclical Buyback (OPPORTUNITY)◆
Repurchased 974,300 shares for NOK 409.6M with volumes rising as prices fell 8.9% — management is stepping up purchases into weakness, a classic value signal
- Brookfield Business Partners (BBU) Portfolio Rotation (OPPORTUNITY)◆
Net income attributable to unitholders swung to +$43M from -$109M despite revenue down 32.4%, and the $1.3B Antylia, $2.6B First National Financial, and ~$950M Fosber deals signal active redeployment into higher-margin businesses
- Lipocine (LPCN) BLOOM Phase 3 (OPPORTUNITY)◆
First participant dosed in the BLOOM Phase 3 study of LPCN 1154 for postpartum depression — a binary clinical catalyst with a defined readout path
- Rentokil Initial (RTO) Buyback (OPPORTUNITY)◆
Repurchased 2,277,347 shares over five days (Nov 2-6) at £3.5187-£3.6051, with the weekly high price on Nov 5 before a pullback to £3.5187 on Nov 6 — steady execution of a buyback program provides a price floor
- CS Disco (LAW) CEO Open-Market Buy (OPPORTUNITY)◆
CEO purchased 4,490 shares at $5.45, adding to a 1.44M-share position — small dollar value but a clear directional signal from the top executive at a depressed price
Sector Themes (6)
- Industrial/Auto Margin Expansion◆
Honda (operating profit +48.1% YoY, SG&A down), Embraer (EBIT margin 10.9% vs 8.6%), and Sony (OI +42.9%) all show operating leverage from cost discipline — 3/3 industrial and consumer-tech names expanded margins YoY, but Honda's implied H2 operating profit of ~¥131B vs H1's ¥648.7B flags a sharp deceleration ahead [IMPLICATION: favor names with H2 visibility like Embraer over those with back-half cliffs like Honda]
- Semiconductor AI Demand Intact but Bifurcated◆
ASE October revenue +47.1% YoY with ATM +57.7% YoY and +7.9% MoM, but non-ATM EMS revenue fell ~10.4% sequentially — the AI packaging boom is masking weakness in legacy EMS, a pattern likely to repeat across the semi supply chain [IMPLICATION: own advanced-packaging exposure, avoid commodity EMS]
- Insider Selling Cluster in High-Multiple Consumer/Growth◆
FIGS ($98.2M tax withholding at $21.58), Progyny (~$10.3M combined CEO/Chairman sales at ~$35.73), Chime ($18.4M DST sale), and Newbury Street ($2.3M Alpine sale) — 4 of the 5 largest insider transactions in the batch are sales, all in consumer-internet or growth names [IMPLICATION: insider conviction is weakest exactly where valuations are richest]
- SPAC/Merger Activity Reaccelerating with PIPE Support◆
ACP Holdings/May Mobility ($120M PIPE, Nov 12 Investor Day) and Werewolf/Ambros (~$697.5M combined valuation, $150M PIPE co-led by RA Capital and Janus Henderson) — both deals are PIPE-backed and roadshow-heavy, signaling renewed risk appetite for de-SPAC transactions [IMPLICATION: watch PIPE pricing and redemption levels as the real tell]
- Capital Return via Buybacks Accelerating Internationally◆
Equinor (974,300 shares, NOK 409.6M), Rentokil (2,277,347 shares over 5 days), and Atour (new cash dividend) — non-US issuers are stepping up shareholder returns, with Equinor notably buying more as prices fell [IMPLICATION: buyback programs provide downside support in European and Asian large caps]
- Distress Concentrated in Micro-Cap Shells◆
Fusemachines (Nasdaq delisting, going-concern, convertible default trigger) and Crona Corp. ($0 cash, zero revenue, $223,934 stockholders' deficit) — both are sub-$10M-market-cap names with structural liquidity failures, distinct from the broader market's health [IMPLICATION: delisting and going-concern risk is idiosyncratic, not systemic]
Watch List (8)
- Embraer (ERJ)👁
Raised 2026 guidance to $8.4-8.6B revenue and >$700M FCF; watch Q4 delivery execution against the 80-85 commercial aircraft target after 9M26 tracked at only 63% of midpoint
-
Investor Day Nov 12, 2026 (3:00-4:30 PM ET) with $120M PIPE; follow-on appearances at Barclays (Nov 19), UBS (Nov 30), Raymond James (Dec 7), and Bernstein (Dec 9) — dense catalyst calendar
- Werewolf Therapeutics (HOWL)👁
Ambros merger at ~$697.5M combined valuation with $150M PIPE; closing expected Q4 2026 subject to stockholder approval, and CRPS-RISE Phase 3 interim analysis (October 2026) is the key binary event
- Fusemachines (FUSE)👁
Nasdaq delisting proceedings and going-concern risk disclosed in S-3; watch for delisting determination and any convertible note default trigger on loss of listing
- Honda (HMC)👁
H2 guidance implies ~80% operating profit decline vs H1 run-rate; watch for any guidance revision or demand commentary at the next earnings update
- Atour Lifestyle (ATAT)👁
Q3 2026 results and cash dividend furnished in 6-K; watch dividend amount and Q4 outlook for China travel demand
- Brookfield Business Partners (BBU)👁
20-F shows revenue down 32.4% but net income attributable to unitholders positive at $43M; watch integration of Antylia ($1.3B), First National Financial ($2.6B), and Fosber (~$950M) and any further disposition announcements
- NexPoint Residential (NXRT)👁
Three insiders bought at $15.91-$16.86 while a director sold at $17.07; watch for additional Form 4 filings to confirm whether the buy-side cluster continues
Filing Analyses
(50)
09-11-2026
Goldman Sachs Asset Management, L.P. filed a Schedule 13G/A disclosing beneficial ownership of 81,600 shares of Onterris, Inc. (formerly Montrose Environmental Group, Inc.) common stock, representing 0.2% of the class as of September 30, 2026. The filing reports sole voting power of 0.00 shares and sole dispositive power of 81,600 shares, with no shared voting or dispositive authority, and certifies the securities were acquired in the ordinary course of business without intent to influence control. The position is passive and immaterial at 0.2% ownership, reflecting no change signal beyond routine reporting.
- · Issuer formerly named Montrose Environmental Group, Inc.; name changed to Onterris, Inc. (date of name change 20150528)
- · Issuer business address: 5120 Northshore Drive, North Little Rock, AR 72118
- · Filing made under Rule 13d-1(b) as a passive institutional investor
- · Sole dispositive power of 81,600 shares; no shared voting or dispositive power
- · Power of Attorney effective July 2, 2026 through July 2, 2027
- · Joint filing agreement dated 10/15/2026
09-11-2026
10% owner Alpine Global Management, LLC sold 130,000 Class A Ordinary Shares at $10.87 (~$1.41M). Alpine Global Management, LLC holds 300,000 shares after the transaction.
- · 10% owner Alpine Global Management, LLC sold 5,382 Class A ordinary shares, par value $0.0001 per share at $11.10 (~$59.7K)
- · 10% owner Alpine Global Management, LLC sold 130,000 Class A Ordinary Shares at $10.87 (~$1.41M)
- · 10% owner Alpine Global Management, LLC sold 80,183 Class A Ordinary Shares at $10.89 (~$873K)
09-11-2026
Chief Executive Officer Spear Catherine Eva had withheld for taxes 4,550,716 Class A Common Stock at $21.58 (~$98.2M). 6 transactions reported in total. Spear Catherine Eva holds 1,671,854 shares after the transaction.
- · Chief Executive Officer Spear Catherine Eva exercised/converted 7,695,000 Class A Common Stock at $0.85 (~$6.54M)
- · Chief Executive Officer Spear Catherine Eva exercised/converted 900,000 Class A Common Stock at $1.37 (~$1.23M)
- · Chief Executive Officer Spear Catherine Eva had withheld for taxes 4,550,716 Class A Common Stock at $21.58 (~$98.2M)
- · Chief Executive Officer Spear Catherine Eva sold 4,044,284 Class A Common Stock at $19.70 (~$79.7M)
- · Chief Executive Officer Spear Catherine Eva exercised/converted 7,695,000 Stock Option (Right to Buy)
- · Chief Executive Officer Spear Catherine Eva exercised/converted 900,000 Stock Option (Right to Buy)
09-11-2026
Director Mitts Brian sold 15,000 Common Stock at $17.07 (~$256K). Mitts Brian holds 45,289 shares after the transaction.
- · Director Mitts Brian sold 15,000 Common Stock at $17.07 (~$256K)
09-11-2026
See Remarks McGraner Matt bought 5,910 Common Stock at $16.86 (~$99.6K). McGraner Matt holds 373,596.6 shares after the transaction.
- · See Remarks McGraner Matt bought 5,910 Common Stock at $16.86 (~$99.6K)
- · See Remarks McGraner Matt bought 6,082 Common Stock at $16.38 (~$99.6K)
09-11-2026
See Remarks Richards Paul bought 3,000 Common Stock at $16.78 (~$50.3K). Richards Paul holds 38,403 shares after the transaction.
- · See Remarks Richards Paul bought 3,000 Common Stock at $16.78 (~$50.3K)
- · See Remarks Richards Paul bought 500 Common Stock at $16.33 (~$8.17K)
- · See Remarks Richards Paul bought 2,800 Common Stock at $15.91 (~$44.5K)
09-11-2026
Chairman and CEO Walsh Joe had withheld for taxes 1,167 Common Shares at $1.18 (~$1.38K). Walsh Joe holds 783,849 shares after the transaction.
- · Chairman and CEO Walsh Joe had withheld for taxes 958 Common Shares at $1.19 (~$1.14K)
- · Chairman and CEO Walsh Joe had withheld for taxes 1,167 Common Shares at $1.18 (~$1.38K)
09-11-2026
Chief Executive Officer Friedrichsen Eric bought 4,490 Common Stock at $5.45 (~$24.5K). Friedrichsen Eric holds 1,441,178 shares after the transaction.
- · Chief Executive Officer Friedrichsen Eric bought 4,490 Common Stock at $5.45 (~$24.5K)
09-11-2026
Toronto Dominion Investments, Inc. and affiliated TD entities (Toronto Dominion Holdings USA, TD Group US Holdings LLC, The Toronto-Dominion Bank) filed Amendment No. 1 to their Schedule 13D regarding 826 Series W-7 Variable Rate Demand Preferred Shares (CUSIP 09255G503) of BlackRock MuniYield Pennsylvania Quality Fund, representing 100% of that VRDP series. The amendment is administrative in nature, reflecting an October 23, 2026 Omnibus Amendment to the June 19, 2019 VRDP Fee Agreement and updating officer/director schedules and exhibits; no change in share count or ownership percentage was reported.
- · Original Schedule 13D dated June 22, 2022 and filed July 6, 2022; this is Amendment No. 1
- · Each of the four reporting persons reports 0.00% of common shares and 826 VRDP shares (100% of the series)
- · Issuer formerly named BlackRock MuniYield Pennsylvania Insured Fund (name change June 20, 2008)
- · Issuer incorporated in New Jersey with fiscal year end June 30
- · Amendment triggered by Omnibus Amendment to Fee Agreements effective October 23, 2026
- · Litigation schedule states no criminal convictions or securities-law injunctions in the past five years for TD entities or listed officers/directors
09-11-2026
Toronto Dominion Investments, Inc. and affiliated TD entities (Toronto Dominion Holdings USA, TD Group US Holdings LLC, The Toronto-Dominion Bank) filed Amendment No. 1 to their Schedule 13D regarding Series W-7 Variable Rate Demand Preferred Shares (CUSIP 092481308) of BlackRock Virginia Municipal Bond Trust. The amendment reflects an administrative update to the VRDP Fee Agreement, effective October 23, 2026, via an Omnibus Amendment to Fee Agreements, and updates the lists of executive officers/directors and exhibits. Each reporting person reports beneficial ownership of 116 VRDP Shares (0.00% of class per the filing's percentage column), with no change in share counts disclosed in this amendment.
- · Amendment No. 1 amends the original Schedule 13D dated June 16, 2020 and filed July 5, 2022
- · Fee agreement amendment became effective October 23, 2026
- · Exhibits replaced: Joint Filing Agreement (99.1), Certificate for TD (99.2), Secretary's Certificate for TD GUS (99.3), and new Omnibus Amendment to Fee Agreements (99.8)
- · Litigation schedule states no criminal convictions or securities-law injunctions in the last five years for TD entities or listed officers/directors
- · Filing signed November 9, 2026 by Christina Petrou (TDI, TDH, TD Bank) and Andre Ramos (TD GUS)
09-11-2026
10% owner DST Global Advisors Ltd sold 591,059 Class A Common Stock at $31.11 (~$18.4M). 21 transactions reported in total. DST Global Advisors Ltd holds 324,365 shares after the transaction.
- · 10% owner DST Global Advisors Ltd sold 4,916 Class A Common Stock at $32.10 (~$158K)
- · 10% owner DST Global Advisors Ltd sold 2,526 Class A Common Stock at $32.10 (~$81.1K)
- · 10% owner DST Global Advisors Ltd sold 424 Class A Common Stock at $32.10 (~$13.6K)
- · 10% owner DST Global Advisors Ltd sold 512 Class A Common Stock at $32.10 (~$16.4K)
- · 10% owner DST Global Advisors Ltd sold 1,488 Class A Common Stock at $32.10 (~$47.8K)
- · 10% owner DST Global Advisors Ltd sold 774 Class A Common Stock at $32.10 (~$24.8K)
- · 10% owner DST Global Advisors Ltd sold 100 Class A Common Stock at $32.10 (~$3.21K)
- · 10% owner DST Global Advisors Ltd sold 591,059 Class A Common Stock at $31.11 (~$18.4M)
09-11-2026
10% owner DST Global Advisors Ltd sold 591,059 Class A Common Stock at $31.11 (~$18.4M). 21 transactions reported in total. DST Global Advisors Ltd holds 324,365 shares after the transaction.
- · 10% owner DST Global Advisors Ltd sold 4,916 Class A Common Stock at $32.10 (~$158K)
- · 10% owner DST Global Advisors Ltd sold 2,526 Class A Common Stock at $32.10 (~$81.1K)
- · 10% owner DST Global Advisors Ltd sold 424 Class A Common Stock at $32.10 (~$13.6K)
- · 10% owner DST Global Advisors Ltd sold 512 Class A Common Stock at $32.10 (~$16.4K)
- · 10% owner DST Global Advisors Ltd sold 1,488 Class A Common Stock at $32.10 (~$47.8K)
- · 10% owner DST Global Advisors Ltd sold 774 Class A Common Stock at $32.10 (~$24.8K)
- · 10% owner DST Global Advisors Ltd sold 100 Class A Common Stock at $32.10 (~$3.21K)
- · 10% owner DST Global Advisors Ltd sold 591,059 Class A Common Stock at $31.11 (~$18.4M)
09-11-2026
Toronto Dominion Investments, Inc. and affiliated TD entities (Toronto Dominion Holdings USA, TD Group US Holdings LLC, The Toronto-Dominion Bank) filed Amendment No. 1 to their Schedule 13D regarding Series W-7 Variable Rate Demand Preferred Shares (CUSIP 09254V600) of BlackRock Muniyield Michigan Quality Fund, Inc. The amendment reflects an administrative update: the VRDP Fee Agreement dated June 16, 2020 was amended by an Omnibus Amendment to Fee Agreements effective October 23, 2026. Each reporting person reports beneficial ownership of 2,319 VRDP shares (0.00% of common equity class, 100% of the VRDP series), with no change in share counts disclosed and no purchases or sales reported.
- · Amendment No. 1 amends the original Schedule 13D dated June 16, 2020 and filed July 5, 2022
- · No change in reported beneficial ownership of 2,319 VRDP shares; 0.00% of common shares, 100% of the VRDP series
- · Filing triggered solely by the Omnibus Amendment to Fee Agreements effective October 23, 2026, not by any purchase or sale of securities
- · Issuer formerly named BlackRock Muniyield Michigan Insured Fund, Inc. (name change June 11, 2007)
- · Schedule II litigation disclosure states no criminal convictions or securities-law judgments against TD entities or listed officers/directors in the past five years
- · Exhibits include Joint Filing Agreement, TD and TD GUS certificates, and the Omnibus Amendment (Exhibit 99.8)
09-11-2026
Toronto Dominion Investments, Inc. and affiliated TD entities (Toronto Dominion Holdings USA, TD Group US Holdings, The Toronto-Dominion Bank) filed Amendment No. 3 to their Schedule 13D, reporting beneficial ownership of 2,010 Series W-7 Variable Rate Demand Preferred Shares (CUSIP 09255E805) of BlackRock MuniYield New York Quality Fund, Inc., representing 39.8% of the class. The amendment is administrative in nature, reflecting an October 23, 2026 Omnibus Amendment to the VRDP Fee Agreement dated February 9, 2026, along with updated officer/director schedules and exhibits. No change in share count or ownership percentage was reported, and the filing discloses no litigation or regulatory actions against the reporting persons.
- · Amendment No. 3 amends the original Schedule 13D dated June 22, 2022 and filed July 5, 2022
- · The VRDP Fee Agreement was amended effective October 23, 2026 via the Omnibus Amendment to Fee Agreements
- · Issuer was formerly named BlackRock MuniYield New York Insured Fund, Inc. (name change June 12, 2007)
- · Issuer fiscal year end is September 30; SEC file number 005-84443
- · Schedule II litigation disclosure states no criminal convictions or securities-law injunctions in the last five years for TD entities or listed officers/directors
- · Exhibits include Joint Filing Agreement, TD and TD GUS certificates, and the Omnibus Amendment (Exhibit 99.14)
09-11-2026
Toronto-Dominion Bank and its affiliates (TDI, TDH, TD GUS) filed Amendment No. 2 to their Schedule 13D regarding 5,877 Series W-7 Variable Rate Demand Preferred Shares (CUSIP 09254E863) of BlackRock MuniYield Quality Fund III, representing 100% of the VRDP class. The amendment is administrative in nature, updating officer/director schedules and reflecting an Omnibus Amendment to Fee Agreements dated October 23, 2026 that amended the February 23, 2026 VRDP Fee Agreement. No change in beneficial ownership occurred — the 5,877 share position and 100% class percentage are unchanged from prior filings.
- · Amendment No. 2 amends the original Schedule 13D dated June 22, 2022 and filed July 5, 2022
- · The VRDP Fee Agreement dated February 23, 2026 was amended effective October 23, 2026 via the Omnibus Amendment to Fee Agreements
- · Exhibits replaced include the Joint Filing Agreement, TD Certificate, TD GUS Secretary's Certificate, Amended and Restated Fee Agreement, and Omnibus Amendment
- · Litigation schedule confirms no criminal convictions or securities-law injunctions for TD Entities or listed officers/directors in the past five years
- · Issuer address: 100 Bellevue Parkway, Wilmington, DE 19809
09-11-2026
See Remarks DiPerna Paul was awarded 150,000 Option to purchase common stock.
- · See Remarks DiPerna Paul was awarded 150,000 Option to purchase common stock
09-11-2026
CHIEF EXECUTIVE OFFICER Anevski Peter sold 126,204 Common Stock at $35.73 (~$4.51M). 8 transactions reported in total. Anevski Peter holds 762,468 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CHIEF EXECUTIVE OFFICER Anevski Peter exercised/converted 3,400 Common Stock at $0.91 (~$3.09K)
- · CHIEF EXECUTIVE OFFICER Anevski Peter sold 3,400 Common Stock at $35.23 (~$120K)
- · CHIEF EXECUTIVE OFFICER Anevski Peter sold 8,539 Common Stock at $35.09 (~$300K)
- · CHIEF EXECUTIVE OFFICER Anevski Peter exercised/converted 126,204 Common Stock at $0.91 (~$115K)
- · CHIEF EXECUTIVE OFFICER Anevski Peter sold 126,204 Common Stock at $35.73 (~$4.51M)
- · CHIEF EXECUTIVE OFFICER Anevski Peter sold 35,104 Common Stock at $35.73 (~$1.25M)
- · CHIEF EXECUTIVE OFFICER Anevski Peter exercised/converted 3,400 Stock Option (Right to Buy)
- · CHIEF EXECUTIVE OFFICER Anevski Peter exercised/converted 126,204 Stock Option (Right to Buy)
09-11-2026
Chief Operating Officer Schmid Kevin was awarded 100,000 Option to purchase common stock.
- · Chief Operating Officer Schmid Kevin was awarded 100,000 Option to purchase common stock
09-11-2026
Executive Chairman Schlanger David J sold 161,208 Common Stock at $35.73 (~$5.76M). 6 transactions reported in total. Schlanger David J holds 238,462 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Executive Chairman Schlanger David J exercised/converted 3,400 Common Stock at $0.91 (~$3.09K)
- · Executive Chairman Schlanger David J sold 3,400 Common Stock at $35.22 (~$120K)
- · Executive Chairman Schlanger David J exercised/converted 161,208 Common Stock at $0.91 (~$147K)
- · Executive Chairman Schlanger David J sold 161,208 Common Stock at $35.73 (~$5.76M)
- · Executive Chairman Schlanger David J exercised/converted 3,400 Stock Option (Right to Buy)
- · Executive Chairman Schlanger David J exercised/converted 161,208 Stock Option (Right to Buy)
31-03-2026
Brookfield Business Partners filed its 2025 20-F reporting revenues of $27,457M, down 32.4% YoY from $40,620M (which itself fell 26.2% from $55,068M in 2023), driven largely by dispositions and deconsolidation. Net income fell 56.8% to $387M from $895M, and net income attributable to Unitholders swung to a $43M profit from a $109M loss, while Adjusted EBITDA declined 6.1% to $2,409M from $2,565M. The company remained active on M&A, completing the $1.3B Antylia Scientific acquisition, the $2.6B First National Financial privatization, and agreeing to acquire Fosber for ~$950M, while total assets were roughly flat at $75,761M versus $75,474M.
- · Segment revenues 2025: Industrials $14,936M, Business services $9,368M, Infrastructure services $3,153M
- · Segment assets at Dec 31, 2025: Industrials $29,914M, Business services $28,578M, Infrastructure services $16,270M, Corporate $999M
- · Geographic revenues 2025: USA $8,797M, Europe $4,846M, Australia $4,130M, Brazil $2,605M, UK $2,149M, Canada $1,754M, Mexico $1,278M, Other $1,898M
- · Basic and diluted loss per limited partner unit was $(0.30) in 2025 vs $(0.50) in 2024 and $6.49 in 2023
- · Q3 2025 net loss of $(122)M and Q4 2025 net income of $118M; Q3 2024 net income was $1,735M
- · Interest expense, net rose to $(3,139)M in 2025 from $(3,104)M in 2024
- · Interest of others in operating subsidiaries fell to $9,120M at Dec 31, 2025 from $11,451M at Dec 31, 2024
- · Goodwill increased $1,071M to $13,310M; property, plant and equipment declined $2,219M to $11,013M
- · Offshore oil services FPSO sale expected to close in first half of 2026; did not meet held-for-sale criteria at Dec 31, 2025
- · Fosber acquisition subject to customary regulatory approvals, expected to close in first half of 2026
27-03-2026
Brookfield Business Partners L.P. filed a 6-K on March 27, 2026 consisting solely of an exhibit list of governance and intercompany agreements, with no financial results or monetary figures disclosed. The filing centers on a series of first amendments dated March 27, 2026 to existing agreements — the Trade-Mark Sublicense Agreement, Master Services Agreement, Relationship Agreement and Commitment Agreement — each adding Brookfield Business Corporation (formerly 1559985 B.C. Ltd.) as a party, alongside a Fourth Amendment to the partnership's Limited Partnership Agreement and a new Registration Rights Agreement between Brookfield Business Corporation and Brookfield Corporation. The pattern of amendments and the corporate name change indicate a reorganization establishing Brookfield Business Corporation within the Brookfield structure, but the filing provides no quantitative detail on terms, consideration or financial impact.
- · All amendments to the Trade-Mark Sublicense Agreement, Master Services Agreement, Relationship Agreement and Commitment Agreement are dated March 27, 2026 and add Brookfield Business Corporation as a party
- · Fourth Amendment to the Amended and Restated Limited Partnership Agreement dated March 27, 2026; prior amendments were dated June 17, 2016, May 18, 2020 and March 15, 2022
- · Registration Rights Agreement is between Brookfield Business Corporation and Brookfield Corporation, dated March 27, 2026
- · Third Amendment to the Commitment Agreement between Brookfield Corporation and Brookfield Business Partners L.P. is dated November 4, 2025; earlier amendments dated May 5, 2022 and November 7, 2023
- · Original Trade-Mark Sublicense Agreement dated May 24, 2016; original Amended and Restated Limited Partnership Agreement dated May 31, 2016
- · Amended and Restated Master Services Agreement and Relationship Agreement both dated January 23, 2024
- · No monetary amounts, financial results or transaction values are disclosed in the filing
31-03-2026
Brookfield Business Partners L.P. filed a 6-K on March 31, 2026, disclosing a Business Acquisition Report dated March 30, 2026, and audited financial statements of Brookfield Business Corporation (formerly 1559985 B.C. Ltd.) for the period October 10, 2025 to December 31, 2025. The filing provides no financial details or transaction terms, leaving the impact on BBU unclear.
- · Audited financial statements cover the period from October 10, 2025 to December 31, 2025.
- · The filing includes an audited statement of financial position as of December 31, 2025, and statements of operating results, changes in equity, and cash flow for the period.
- · The Business Acquisition Report is dated March 30, 2026.
- · No financial figures or transaction terms were disclosed in the filing excerpt.
31-03-2026
Brookfield Business Corporation filed a Form 6-K on March 31, 2026, disclosing a press release dated the same day as Exhibit 99.1, signed by CFO Jaspreet Dehl. The filing text contains no financial results, transaction terms, or monetary figures, so no period-over-period metrics can be assessed. The substantive content resides in the referenced press release, which is not included in the provided text.
- · Registrant is a foreign private issuer filing under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
- · Commission File Number: 000-56830
- · Registrant files annual reports under Form 20-F (Form 40-F not selected)
- · Principal executive office: Brookfield Place, 225 Liberty Street, 8th Floor, New York, NY 10281-1048
- · Exhibit 99.1 is a press release dated March 31, 2026; its contents are not reproduced in the filing text
02-04-2026
Brookfield Business Corporation filed a Form 6-K on April 2, 2026, disclosing a Notice of Record and Meeting Date (Exhibit 99.1) for an upcoming shareholder meeting. The filing contains no financial results, monetary amounts, or period-over-period performance data, and was signed by A.J. Silber, Managing Director and Corporate Secretary. It is a routine administrative disclosure with no material financial metrics.
- · Commission File Number: 000-56830
- · Registrant files annual reports under Form 20-F (not Form 40-F)
- · Principal executive office located at Brookfield Place, 225 Liberty Street, 8th Floor, New York, NY 10281-1048
- · Filing made for the month of April 2026
- · Exhibit 99.1 is the sole exhibit attached to the filing
08-05-2026
Brookfield Business Corporation filed a Form 6-K on May 8, 2026, disclosing a press release (Exhibit 99.1) dated the same day, signed by CFO Jaspreet Dehl. The filing cover page contains no financial figures, period-over-period comparisons, or operational metrics, so no performance assessment is possible from this document alone.
- · Commission File Number: 000-56830
- · Registrant files annual reports under Form 20-F
- · Principal executive office: Brookfield Place, 225 Liberty Street, 8th Floor, New York, NY 10281-1048
- · Press release referenced as Exhibit 99.1 dated May 8, 2026, but its substantive content is not included in the filing text provided
11-05-2026
Brookfield Business Corporation filed a Form 6-K on May 11, 2026, furnishing its interim report for the quarter ended March 31, 2026, along with CEO and CFO certifications (Form 52-109F2). The filing is a routine foreign private issuer cover report and does not itself disclose specific financial figures, revenue, or period-over-period comparisons in the provided text. No positive, negative, or flat performance metrics can be assessed from the filing content shown.
- · Interim report covers the quarter ended March 31, 2026
- · Commission File Number: 000-56830
- · Registrant files annual reports under Form 20-F
- · Exhibits include CEO and CFO certifications under Form 52-109F2
- · Principal executive office located at Brookfield Place, 225 Liberty Street, 8th Floor, New York, NY 10281-1048
20-05-2026
Brookfield Business Corporation filed a Form 6-K on May 20, 2026, furnishing materials for its Annual General Meeting of Shareholders, including a Management Information Circular (Exhibit 99.1), Notice of AGM and Availability of Investor Materials (Exhibit 99.2), and Form of Proxy (Exhibit 99.3). The Exhibit 99.1 circular is incorporated by reference into the company's Form F-10 registration statement (File No. 333-294846). The filing contains no financial results, transaction terms, or period-over-period performance data.
- · Commission File Number: 000-56830
- · Form F-10 registration statement File No. 333-294846 incorporates Exhibit 99.1 by reference
- · Registrant files annual reports under Form 20-F
- · Principal executive office: Brookfield Place, 225 Liberty Street, 8th Floor, New York, NY 10281-1048
- · Filing signed May 20, 2026 by A.J. Silber
06-11-2026
Fusemachines filed an S-3 shelf registration on November 6, 2026, authorizing up to 505,000,000 shares (500,000,000 common at $0.0001 par and 5,000,000 preferred at $0.0001 par), with 32,544,711 common shares outstanding as of November 3, 2026 and no preferred designated. The filing discloses significant negatives: Nasdaq continued-listing deficiencies and related delisting proceedings, liquidity and going-concern risks, and restrictions/repayment obligations under August 2026 convertible notes, with loss of exchange listing potentially triggering a default. Proceeds are earmarked for general corporate purposes with no acquisitions currently planned, and the company does not intend to pay cash dividends in the foreseeable future.
- · Board is divided into three staggered classes (Class I, II, III) with three-year terms; Class I directors elected at June 9, 2026 annual meeting for terms expiring 2029
- · Directors may be removed only for cause by holders of at least 66 2/3% of voting power
- · Special meetings of stockholders may be called only by the board, Chairperson, CEO or President
- · Certificate of Incorporation does not authorize cumulative voting
- · Transfer agent and warrant agent is Continental Stock Transfer & Trust Company
- · Company has not designated any series of preferred stock as of November 3, 2026
- · No current plans, commitments or agreements with respect to any acquisition as of the prospectus date
- · Pending use, proceeds may be invested in short-term/intermediate-term interest-bearing obligations, investment-grade instruments, CDs or U.S. government obligations
10-11-2026
ASE Technology Holding reported October 2026 net revenues of NT$88,615 million (US$2,779 million), up 47.1% YoY but only +0.6% sequentially, indicating a sharp deceleration versus September. The ATM (packaging/testing) segment drove growth with NT$56,840 million (US$1,783 million), up 57.7% YoY and +7.9% sequentially, while implied non-ATM revenue was roughly flat to slightly down sequentially.
- · Implied non-ATM (EMS/other) revenue was approximately NT$31,775 million in Oct 2026 vs NT$35,456 million in Sept 2026, a sequential decline of roughly 10.4%
- · ATM segment accounted for about 64% of consolidated October 2026 revenue
- · Consolidated sequential growth of +0.6% (NT$) lagged ATM's +7.9%, implying weakness in the non-ATM business
- · US$ figures reflect a different implied FX rate than NT$ figures, producing divergent YoY growth rates (47.1% NT$ vs 40.4% US$)
10-11-2026
Embraer reported its best-ever Q3 revenue of US$2.3 bn (+17% YoY from US$2,004 m), with revenue growth across all four divisions and adjusted EBIT margin expanding to 10.9% (from 8.6%). Backlog hit a record US$35.7 bn (8th consecutive all-time high, +14% YoY), and the company raised 2026 guidance for revenue to US$8.4-8.6 bn and FCF to >US$700 m. However, adjusted net income declined to US$74 m (3.1% margin) from US$84 m (4.2%) a year earlier, and 9M26 commercial deliveries of 52 aircraft tracked at only 63% of guidance mid-point versus 70% for executive aviation, signaling back-half loading risk.
- · Book-to-bill LTM: Consolidated 1.5x; Commercial Aviation 1.2x; Executive Aviation 1.4x; Defense & Security 2.9x; Services & Support 1.3x
- · Backlog mix 3Q26: Commercial Aviation US$15.8 bn, Executive Aviation US$8.2 bn, Defense & Security US$6.1 bn, Services & Support US$5.6 bn
- · 3Q26 adjusted EBIT margin ex U.S. tariffs and tax credits: 16.0% vs 14.7% in 3Q25
- · Defense & Security adj. EBIT margin 17.0% ex tariffs/tax credits vs 14.1% prior year
- · Services & Support EBIT US$108 m (+US$40 m YoY), margin 17.0% (+330bp)
- · Commercial Aviation EBIT US$17 m (+US$9 m YoY), margin 2.4% (+110bp)
- · Executive Aviation EBIT US$105 m (+US$34 m YoY), margin 16.0% (+390bp)
- · Defense & Security EBIT US$54 m (+US$18 m YoY), margin 15.7% (+280bp)
- · 2026 guidance: Commercial deliveries 80-85, Executive deliveries 160-170, Adj. EBIT margin 10.0%-10.6%
- · 9M26 adjusted EBITDA US$816 m vs US$396 m 5Y average; adjusted EBIT US$646 m vs US$251 m 5Y average
- · 9M26 adjusted FCF at 6.8% of mid-point revenue vs -4.0% 5Y average
- · Net cash without Eve / Adj. EBITDA: 0.4x in 3Q26 vs 0.1x in 3Q25; gross debt US$1,115 m with 8.7-year average maturity and 5.1% average cost
- · Eve prototype: 73 total flights, 3h 06min total flight time, 170 points validated, 91% of flight campaign complete
- · Shareholder remuneration: 2Q26 IoE R$200.0 m (R$0.28/share, US$0.22/ADS), 3Q26 IoE R$154.0 m (R$0.22/share, US$0.17/ADS)
- · Farnborough drove 28 E2 firm orders from Abra Group, Binter and Luxair; ANA ordered 8 additional E190-E2 bringing total to 23 aircraft
- · Colombia ordered 2 KC-390 Millennium aircraft
10-11-2026
On Holding AG filed a Form 6-K on November 10, 2026, furnishing a press release and Management's Discussion and Analysis covering the third quarter ended September 30, 2026. The filing itself contains only cover-page, signature, incorporation-by[redacted], and exhibit-index information; the substantive financial figures reside in Exhibits 99.1 and 99.2, which are not reproduced in the provided text. No quantitative results, period-over-period comparisons, or segment performance data can be verified from the filing body as presented.
- · Filing is a Form 6-K for the month of November 2026 under Commission File Number 001-40795
- · Report covers the third quarter ended September 30, 2026
- · Exhibit 99.1 is a press release dated November 10, 2026
- · Exhibit 99.2 is Management's Discussion and Analysis of Financial Condition and Results of Operations for Q3 2026
- · Report is incorporated by reference into Form F-3 (Registration No. 333-291559) and Form S-8 (Registration Nos. 333-259533, 333-268853 and 333-293976)
- · Principal executive office: Förrlibuckstrasse 190, 8005 Zurich, Switzerland; Tel +41 44 225 1555
- · Registrant files annual reports under Form 20-F
- · Signed by Frank Sluis, Chief Financial Officer, dated November 10, 2026
- · No actual revenue, margin, or growth figures are present in the filing text provided — financials are in the exhibits
10-11-2026
Crona Corp. reported zero revenues for the three months ended March 31, 2026, with a net loss of $6,567 compared to a net profit of $520 in the prior-year period, driven by the absence of a $35,966 debt forgiveness benefit. Total operating expenses declined 90% to $2,942 from $29,799, but interest expense of $3,625 and a $1,894 increase in director-funded payables contributed to the loss, while total liabilities rose to $232,765 and stockholders' deficit widened to $223,934.
- · Cash balance was $0 at both March 31, 2026 and December 31, 2025.
- · Net cash used in operating activities was $0 in Q1 2026 versus $29,823 in Q1 2025.
- · No financing activities occurred in Q1 2026, compared to $29,823 in related-party advances in Q1 2025.
- · Property, plant and equipment, net decreased to $8,831 from $9,879 due to depreciation.
- · Intangible assets are fully amortized with gross value of $75,020 and accumulated amortization of $75,020.
- · General and administrative expenses were $894 in Q1 2026 versus $0 in Q1 2025.
- · Professional fees fell to $1,000 from $22,500 YoY.
- · Depreciation and amortization expense was $1,048 in Q1 2026 versus $7,299 in Q1 2025.
- · Interest payable increased to $49,289 from $45,664 at December 31, 2025.
- · Related party advances due to director increased to $60,047 from $58,153.
- · Accumulated deficit widened to $423,947 from $417,380.
- · The company reported no provision for income taxes in either period.
10-11-2026
Equinor ASA disclosed daily transactions under the fourth tranche of its 2026 share buy-back programme, repurchasing 709,000 shares on the Oslo Stock Exchange (OSE) between 2-6 November at a weighted average price of NOK 412.6135, for a total value of NOK 292,543,005.80. Combined with previously disclosed buy-backs of 265,300 shares (NOK 117,007,167.13), accumulated tranche repurchases reached 974,300 shares for NOK 409,550,172.93 at an average of NOK 420.3533. Notably, the daily weighted average purchase price declined steadily from NOK 432.9401 on 2 November to NOK 394.4364 on 6 November (down ~8.9%), while daily volumes rose from 136,000 to 149,000 shares, indicating the company bought more shares as prices fell.
- · All transactions occurred on the Oslo Stock Exchange (OSE); no volume reported on CEUX or TQEX venues.
- · Daily volumes rose each day: 136,000 (2 Nov), 138,000 (3 Nov), 141,000 (4 Nov), 145,000 (5 Nov), 149,000 (6 Nov).
- · Daily weighted average prices fell each day: NOK 432.9401, 423.4547, 413.6650, 400.8870, 394.4364.
- · Weighted average price for the 2-6 November period (NOK 412.6135) was 6.4% below the previously disclosed tranche average (NOK 441.0372).
- · Equinor is listed on OSE (EQNR), NYSE (EQNR), CEUX (EQNRO) and TQEX (EQNRO).
10-11-2026
ING Groep N.V. filed a Form 6-K on November 10, 2026, disclosing that it issued a press release the same day, attached as Exhibit 99.1 and incorporated by reference. The filing itself contains no financial figures, performance metrics, or period-over-period comparisons — only administrative cover-page and signature details (signed by Raymond Vermeulen, Head of Media Relations & Issue Management). The substantive content resides in the referenced exhibit, which was not included in the provided text.
- · Commission File Number: 001-14642
- · Registrant files annual reports under Form 20-F (Form 40-F not selected)
- · Principal executive office: Bijlmerdreef 106, 1102 CT Amsterdam, The Netherlands
- · Filing covers the month of November 2026
- · Press release dated November 10, 2026 attached as Exhibit 99.1 (content not included in filing text)
10-11-2026
Cycurion, Inc. filed an 8-K on November 10, 2026 disclosing that on November 4, 2026 it issued a press release, furnished as Exhibit 99.1, under Item 8.01 (Other Events). The filing itself contains no financial results, revenue, or period-over-period metrics — only cover-page and signature details — so no quantitative performance comparison is possible. The substantive content resides in the referenced press release, which is not reproduced in the filing text.
- · Date of earliest event reported: November 4, 2026; filing date: November 10, 2026
- · Press release dated November 4, 2026 furnished as Exhibit 99.1; Inline XBRL cover page as Exhibit 104
- · Company is an emerging growth company (elected not to use extended transition period)
- · Commission File Number 001-41214; IRS EIN 86-3720717; incorporated in Delaware
- · Principal executive offices: 1640 Boro Place, Suite 420C, McLean, Virginia 22102
- · Common stock and warrants listed on The NASDAQ Stock Market LLC under symbols CYCU and CYCUW
- · No financial statements, revenue figures, or period-over-period comparisons included in the filing body
10-11-2026
Rentokil Initial plc repurchased a total of 2,277,347 ordinary shares across five trading days from November 2-6, 2026, at volume-weighted prices ranging from £3.5187 to £3.6051 per share. The daily purchase volume declined steadily through the week, from 464,386 shares on Nov 2 to 449,769 shares on Nov 6 (-3.1%), while the volume-weighted price rose to a weekly high of £3.6051 on Nov 5 before falling back to £3.5187 on Nov 6.
- · Intraday price range on 2026-11-02: low £3.4780, high £3.5730
- · Intraday price range on 2026-11-03: low £3.5200, high £3.5640
- · Intraday price range on 2026-11-04: low £3.4950, high £3.6030
- · Intraday price range on 2026-11-05: low £3.5770, high £3.6340
- · Intraday price range on 2026-11-06: low £3.4780, high £3.5550
- · Weekly high price paid was £3.6340 on 2026-11-05; weekly low was £3.4780 (on both 2026-11-02 and 2026-11-06)
10-11-2026
HDFC Bank Limited filed a routine Form 6-K with the SEC for the month of November 2026, containing only a signature page executed by Company Secretary Ajay Agarwal and an exhibit index referencing a single 'Disclosure' document (Exhibit 99). The filing discloses no financial figures, performance metrics, or period-over-period comparisons, making it a procedural administrative submission rather than a substantive financial update.
- · Commission File Number: 001-15216
- · Filing covers the month of November 2026
- · Registrant files annual reports under Form 20-F (not Form 40-F)
- · Principal executive office located at HDFC Bank House, Senapati Bapat Marg, Lower Parel, Mumbai 400 013, India
- · Signed on November 06, 2026
- · Exhibit 99 referenced as 'Disclosure' but its contents are not included in the filing text
10-11-2026
Braze, Inc. filed a DEFA14A on November 10, 2026, disclosing that it intends to file a preliminary proxy statement on Schedule 14A in connection with a proposed transaction involving 'Parent' and the Company. The filing is a routine additional solicitation/proxy communication containing forward-looking statement disclaimers and boilerplate language; it discloses no financial terms, deal value, or consideration for the proposed transaction. No quantitative financial or operational metrics were provided.
- · Company intends to file a preliminary proxy statement on Schedule 14A with the SEC in connection with the proposed transaction
- · Definitive proxy statement will be delivered to shareholders as required by applicable law
- · Company's 2026 Annual Meeting Proxy Statement was filed with the SEC on May 18, 2026
- · Company and certain directors, executive officers and employees may be deemed participants in the proxy solicitation
- · Documents available free of charge at SEC's website (www.sec.gov) and Braze investor relations site (investors.braze.com)
- · Filing explicitly states it is not an offer to buy or sell securities nor a solicitation of any vote or approval
10-11-2026
Embraer revised its 2026 guidance on November 10, 2026, raising Consolidated Net Revenues to $8.4–8.6B (from $8.2–8.5B) and Free Cash Flow to $700M or higher (from $400M or higher), while keeping Adjusted EBIT Margin at 10.0%–10.6%. Commercial Aviation deliveries were unchanged at 80–85 aircraft and Executive Aviation deliveries flat at 160–170 aircraft, indicating the upgrade is driven by revenue/margin mix and cash generation rather than higher unit volumes.
- · Guidance excludes Eve from the projections
- · Free Cash Flow defined as net cash from operating activities less net PP&E additions and intangible asset additions
- · Prior guidance was originally published March 6, 2026 and revised August 10, 2026
- · Updated projections to be reflected in Section 3 of the Company's Reference Form
- · Company notes projections are subject to risks and uncertainties and may differ materially from actual results
10-11-2026
Atour Lifestyle Holdings filed a Form 6-K on November 10, 2026, furnishing two press releases: its unaudited third quarter 2026 financial results and the announcement of a cash dividend. The filing itself contains only cover-page and signature information, with the substantive financial figures and dividend amount residing in Exhibits 99.1 and 99.2, which were not included in the provided text. No period-over-period metrics can be computed from the filing body.
- · Filing is a Form 6-K under Rule 13a-16/15d-16 of the Securities Exchange Act of 1934 for the month of November 2026
- · Commission File Number: 001-40540
- · Registrant files annual reports under Form 20-F
- · Principal executive office: 1st floor, Wuzhong Building, 618 Wuzhong Road, Minhang District, Shanghai, 201103, People's Republic of China
- · Exhibit 99.1: Press Release — Third Quarter 2026 Unaudited Financial Results
- · Exhibit 99.2: Press Release — Cash Dividend announcement
- · Signed by Haijun Wang, Chairman of the Board of Directors and Chief Executive Officer, dated November 10, 2026
- · No financial figures, dividend per share amount, or period comparisons are present in the filing body itself
10-11-2026
Baozun Inc. filed a routine Form 6-K on November 10, 2026, signed by CEO Vincent Wenbin Qiu, disclosing only the date of a board meeting via Exhibit 99.1. The filing contains no financial results, revenue figures, or period-over-period comparisons, and consists largely of boilerplate forward-looking safe harbor language. No quantitative performance data was disclosed, making this a low-materiality administrative filing.
- · Commission File Number: 001-37385
- · Principal executive office located at No. 1-9, Lane 510, West Jiangchang Road, Shanghai 200436, People's Republic of China
- · Registrant files annual reports under Form 20-F
- · Exhibit 99.1 covers the 'Date of Board Meeting' — the actual meeting date is not specified in the filing text
- · Filing signed and dated November 10, 2026
10-11-2026
Sony Group reported H1 FY2026 (six months ended September 30, 2026) sales of ¥6,267,217 million, up 9.4% from ¥5,729,522 million a year earlier, with operating income rising 42.9% to ¥1,098,828 million and net income attributable to stockholders up 32.2% to ¥791,764 million. However, cash and cash equivalents fell to ¥2,009,334 million from ¥2,667,965 million, total assets dropped sharply to ¥16,667,715 million from ¥36,127,949 million, and net cash used in investing activities widened to ¥607,828 million from ¥393,971 million. The prior fiscal year ended March 31, 2026 showed a net loss attributable to stockholders of ¥326,865 million despite full-year sales of ¥12,479,620 million.
- · Diluted EPS was ¥134.30 in H1 FY2026 vs ¥99.22 in H1 FY2025; fiscal year ended March 31, 2026 diluted EPS was -¥54.36
- · Ratio of stockholders' equity to total assets rose to 51.3% at September 30, 2026 from 21.3% a year earlier and 51.8% at March 31, 2026
- · Net cash used in financing activities narrowed to ¥229,349 million in H1 FY2026 from ¥383,371 million in H1 FY2025
- · Fiscal year ended March 31, 2026 net loss attributable to stockholders was ¥326,865 million (basic EPS -¥54.70) despite operating income of ¥1,447,507 million
- · MD&A presents net income attributable to stockholders for H1 FY2025 as ¥570.5 billion, differing from the ¥598,877 million in the selected financial data table
10-11-2026
Lipocine Inc. filed an 8-K on November 10, 2026, announcing via press release that the first participant has been dosed in its BLOOM Phase 3 Study of LPCN 1154 for postpartum depression. The filing is a clinical milestone update with no financial figures, revenue, or period-over-period data disclosed; it carries no monetary amounts and no operational or financial metrics to compare.
- · First participant dosed in the BLOOM Phase 3 Study of LPCN 1154
- · LPCN 1154 is being developed for postpartum depression
- · Press release furnished as Exhibit 99.1; cover page XBRL as Exhibit 104
- · Common stock trades on NASDAQ under symbol LPCN, par value $0.0001 per share
- · Company is not an emerging growth company
- · No financial amounts, revenue, or period-over-period comparisons were disclosed in this filing
10-11-2026
Value Base Ltd. filed its Q3 2026 13F-HR disclosing a concentrated portfolio of Israeli and Israel-linked technology equities as of September 30, 2026. The largest disclosed positions by share count are Teads Holding (5,752,107 shares), Cognyte Software (3,869,084 and 2,583,798 shares across two lots), Audiocodes (2,628,864 shares), and Valens Semiconductor (11,284,324 and 10,218,831 shares across two lots). The filing contains no period-over-period performance data, so no growth or decline metrics can be calculated; it is a static holdings snapshot rather than an operating update.
- · All reported positions carry sole voting and sole dispositive authority (DFND designation) with zero shared voting or dispositive authority.
- · Filing covers the period ended September 30, 2026, and was signed on November 10, 2026.
- · Value Base Ltd. is an Israeli company controlled by Victor Shamrich and Ido Nouberger; the Management Company is controlled by Value Base Ltd.
- · The filing disclaims beneficial ownership except to the extent of pecuniary interest.
- · Dual-listed 13(f) securities are included only if purchased in the U.S., per informal SEC Division of Investment Management guidance.
- · SEC file number 028-24903; film number 261537707; CIK 0001992355.
- · No dollar values, market values, or period-over-period changes are disclosed in the extracted content.
10-11-2026
Kenon Holdings filed a Form 6-K furnishing the English convenience translations of subsidiary OPC Energy Ltd.'s periodic report for the nine-month and three-month periods ended September 30, 2026, as published to the Israeli Securities Authority and Tel Aviv Stock Exchange on November 10, 2026. The filing itself contains no standalone financial figures — the actual results are in Exhibits 99.1 (Board of Directors report) and 99.2 (unaudited condensed consolidated interim financial statements), which are not included in the provided text. The filing is dominated by extensive forward-looking statements covering OPC/CPV Group project pipeline (Hadera Expansion, Ramat Beka, Sorek 2, Basin Ranch, Shay, Walker), the Zomet plant repair, PJM capacity prices, data center electricity supply in Israel, and Middle East military-operation risks, but provides no period-over-period performance data to assess.
- · Filing date and report date: November 10, 2026; reporting periods: nine-month and three-month periods ended September 30, 2026
- · Exhibits 99.1 and 99.2 are incorporated by reference into Kenon's Form S-8 registration statement (File No. 333-201716)
- · Exhibits are English convenience translations from Hebrew; the Hebrew version prevails in case of discrepancy
- · Kenon files annual reports under Form 20-F; Commission File Number 001-36761
- · Registered office: 1 Temasek Avenue #37-02B, Millenia Tower, Singapore 039192
- · No financial figures, revenue, profit, or period-over-period comparisons are included in the filing text itself — all results reside in the referenced exhibits
10-11-2026
WESCO International filed an 8-K under Regulation FD disclosing a virtual investor event held November 10, 2026, titled 'Data Center Leadership: One Partner, Complete Lifecycle, Around the World,' presented by executive management and focused on the company's end-to-end value proposition across all business units. The filing includes an investor slide presentation (Exhibit 99.1) and contains no financial results, guidance figures, or period-over-period metrics, so no performance comparisons can be assessed. The disclosure is informational in nature and does not represent a regulatory action against the company.
- · Virtual investor event webcast began at approximately 10:00 a.m. ET on November 10, 2026
- · Slide presentation attached as Exhibit 99.1, dated November 10, 2026
- · Filing furnished under Item 7.01 (Regulation FD) and Item 9.01; information is not deemed 'filed' under Section 18 of the Exchange Act
- · Common Stock (par value $0.01 per share) trades on the NYSE under ticker WCC
- · Company headquarters: 225 West Station Square Drive, Suite 700, Pittsburgh, Pennsylvania 15219
- · No financial results, revenue, earnings, or guidance figures were disclosed in this filing
10-11-2026
Honda reported H1 FY2026 (six months ended Sep 30, 2026) sales revenue of ¥12,037,658 million, up 13.2% YoY, with operating profit surging 48.1% to ¥648,737 million and profit attributable to owners up 65.7% to ¥516,761 million (EPS ¥132.75 vs ¥76.30). However, comprehensive income fell 21.7% YoY to ¥382,707 million and 'Other, net' within finance income swung to a ¥48,400 million loss from a ¥25,972 million gain, while R&D spending declined to ¥495,563 million from ¥584,250 million. The company forecasts full-year sales of ¥24,400,000 million (+11.9%) but only ¥780,000 million operating profit and ¥500,000 million profit attributable to owners (EPS ¥128.44), implying a sharp H2 deceleration versus H1 run-rate.
- · Selling, general and administrative expenses fell to ¥1,076,005 million from ¥1,126,526 million YoY
- · Cost of sales rose to ¥9,817,353 million from ¥8,483,760 million YoY
- · Interest expense increased to ¥42,273 million from ¥29,348 million
- · Share of profit of equity-method investments rose to ¥85,294 million from ¥10,895 million
- · Income tax expense was ¥180,660 million vs ¥178,763 million prior year
- · Non-controlling interests profit was ¥43,430 million vs ¥36,827 million
- · Annual dividend per share of ¥70.00 (interim ¥35.00) maintained for FY ending March 31, 2027
- · Full-year FY2026 forecast profit before income taxes ¥790,000 million and profit for the year ¥580,000 million
- · Full-year FY2026 forecast EPS ¥128.44, below H1 annualized EPS of ¥265.50
- · Property, plant and equipment rose to ¥3,744,102 million from ¥3,196,382 million at Mar 31, 2026
- · Non-current financing liabilities increased to ¥8,956,593 million from ¥8,475,151 million
- · Other components of equity declined to ¥2,770,632 million from ¥3,047,489 million
10-11-2026
Alphatime Acquisition Corp filed its Form 10-K annual report on November 10, 2026, a special purpose acquisition company (SPAC) disclosure consisting almost entirely of forward-looking statement caveats, acquisition criteria, and risk factors rather than operating results. The filing contains no revenue, earnings, or period-over-period financial figures, and no business combination has been consummated, so there are no positive or negative operating metrics to compare. Key disclosed terms include warrant exercise-price adjustment triggers tied to a $9.50 per share Newly Issued Price and a $16.50 per share redemption trigger, with no quantitative financial performance data provided.
- · Warrant exercise price adjusts to 115% of the greater of Market Value and Newly Issued Price if shares are issued below $9.50 and gross proceeds exceed 60% of total equity proceeds
- · Redemption trigger price adjusts to 165% of Market Value and Newly Issued Price under the same conditions
- · No revenue, earnings, or operating financial results were disclosed in the filing
- · Filing is dominated by forward-looking statement caveats and risk factors rather than financial performance
10-11-2026
ACP Holdings Acquisition Corp. (Nasdaq: ACGC) filed a Rule 425 communication regarding its proposed business combination with autonomous vehicle technology company May Mobility, Inc., announced September 16, 2026. May Mobility will host an Investor Day on November 12, 2026 (3:00–4:30 PM ET) as part of its path toward a Nasdaq listing, supported by a fully committed $120 million PIPE. The filing contains no financial results or period-over-period performance data, so no growth or decline metrics can be assessed; it is a procedural M&A communication with no new deal terms disclosed.
- · Proposed business combination between ACP Holdings and May Mobility was announced September 16, 2026
- · Investor Day scheduled Thursday, November 12, 2026, 3:00 PM – 4:30 PM ET, with virtual registration available
- · Upcoming conference appearances: Barclays Global Automotive and Mobility Tech Conference (November 19, 2026, New York), UBS Global Technology and AI Conference (November 30, 2026, Scottsdale), Raymond James TMT Conference (December 7, 2026, New York), Bernstein Industrials & Energy Conference (December 9, 2026, New York)
- · ACP Holdings Commission File No.: 001-43225; ACP Holdings address: 3131 Eastside Street, Houston, Texas 77098; May Mobility address: 650 Avis Drive, Suite 100, Ann Arbor, Michigan 48108
- · Transaction is subject to a Form S-4 registration statement (including proxy statement/prospectus) to be filed with the SEC; closing is conditioned on shareholder approval and other customary conditions
- · Forward-looking statements flag risks including redemption requests by ACP public shareholders, failure to meet Nasdaq listing standards, and possible termination of the business combination agreement
10-11-2026
Werewolf Therapeutics filed a Rule 425 communication containing Ambros Therapeutics' November 2026 Analyst Day presentation detailing their proposed reverse triangular merger. The combined company is anticipated to be valued at ~$697.5M at closing, with Ambros implied at $500M and Werewolf at $47.5M, alongside a concurrent $150M PIPE co-led by RA Capital Management and Janus Henderson Investors. Pro forma ownership splits ~72.0% Ambros, ~21.6% PIPE investors, and only ~6.4% Werewolf, with closing expected in Q4 2026; however, the transaction remains subject to stockholder approvals and closing conditions, and the lead asset neridronate has no FDA approval and depends on a single Phase 3 (CRPS-RISE) that may not stop early for efficacy.
- · Neridronate holds FDA Breakthrough Therapy, Fast Track, and Orphan Drug Designations
- · FDA aligned on a single pivotal Phase 3 (CRPS-RISE) and on including an interim analysis (October 2026)
- · Neridronate approved in Italy for CRPS, but Italian commercialization rights are not held by Ambros
- · Ambros received Notice of Allowance for neridronate method-of-use patent in March 2026, potentially extending exclusivity to 2045
- · First patient dosed in CRPS-RISE in June 2026; trial currently recruiting
- · Werewolf's legacy pipeline is addressed through a CVR
- · Combined company to be renamed Ambros Therapeutics, Inc. and trade on Nasdaq under ticker 'AMBX'
- · CRPS-1 typical onset age 40-60, more frequent in women; no FDA-approved therapies exist
- · Interim analysis may not meet prespecified statistical threshold to stop early for efficacy, requiring trial to continue to final analysis
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →November 10, 2026
US SEC Filings Daily Market Digest — November 10, 2026
US SEC Filings Daily Market Digest
November 10, 2026
Contract Deobligations Alert — November 10, 2026
Contract Deobligations Alert
November 10, 2026
DHS Homeland Security Contracts — November 10, 2026
DHS Homeland Security Contracts
November 10, 2026
VA Healthcare & Services Contracts — November 10, 2026
VA Healthcare & Services Contracts